In 2006, Dr. Michael Weitz was diagnosed with lung cancer following a visit to his internist to obtain an answer to why swallowing cold liquids was uncomfortable. After ruling out a pre-ulcer condition, Dr. Weitz went for a chest X-ray. The X-ray showed a small abnormality, so Dr. Weitz ordered his own CT scan. When the first reading returned an unsatisfactory answer, he pursued a second opinion. Dr. Weitz was finally diagnosed with lung cancer and a prognosis of three to six months to live. After chemo, radiation, and a left lung resection, the cancer metastasized to his brain and bones.
Dr. Weitz is now enrolled in his third successful clinical trial where oral medications go directly after the cancer tumors. “There is no advancement in research without clinical trials,” says Dr. Weitz, “I owe my life to targeted therapies and personalized medicine.” Dr. Weitz is the Associate Director of the Emergency Department at St. John’s Health Center in Santa Monica, California where he practices emergency medicine. He also serves on the Scientific Advisory Board of the Lung Cancer Foundation of America (LCFA).